 | 89bio (NASDAQ:ETNB) Raised to Buy at Bank of America
americanbankingnews.com - September 25 at 10:45 AM |
| 89bio (NASDAQ:ETNB) Rating Increased to Buy at BofA Securities
americanbankingnews.com - September 25 at 9:57 AM |
| Orbimed Advisors Llc Sells 275,000 Shares of 89bio (NASDAQ:ETNB) Stock
americanbankingnews.com - September 23 at 9:30 PM |
| 89bio (NASDAQ:ETNB) Director Ra Capital Management, L.P. Acquires 1,300,000 Shares
americanbankingnews.com - September 21 at 6:51 PM |
| 89bio (NASDAQ:ETNB) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - September 20 at 8:28 AM |
| 89bio (NASDAQ:ETNB) Trading Down 14.7%
americanbankingnews.com - September 17 at 8:52 PM |
| 89bio (NASDAQ:ETNB) Short Interest Update
americanbankingnews.com - September 17 at 8:11 AM |
 | 89bio prices upsized equity offering at $28
seekingalpha.com - September 17 at 1:45 AM |
| 89bio (NASDAQ:ETNB) Price Target Increased to $58.00 by Analysts at BTIG Research
americanbankingnews.com - September 15 at 9:11 AM |
| 89bio (NASDAQ:ETNB) PT Raised to $95.00
americanbankingnews.com - September 15 at 8:28 AM |
| 89Bio readies equity offering
seekingalpha.com - September 15 at 8:22 AM |
 | MRNS Catches Eye, SAVA Soars On Alzheimer's Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMU
nasdaq.com - September 15 at 3:21 AM |
|
| 89Bio readies public offering
seekingalpha.com - September 14 at 10:21 PM |
| 89bio's lead drug shows positive effect in NASH study
seekingalpha.com - September 14 at 12:21 PM |
| 89bio (NASDAQ:ETNB) Shares Gap Up to $34.56
americanbankingnews.com - September 14 at 11:43 AM |
 | 89bio Announces Positive Topline Results from its Phase 1b/2a Trial of BIO89-100 in NASH
finance.yahoo.com - September 14 at 7:20 AM |
 | 89bio to Announce Topline Results from Phase 1b/2a Study of BIO89-100 in NASH
feeds.benzinga.com - September 13 at 8:27 PM |
| 89bio (NASDAQ:ETNB) Shares Gap Up to $37.24
americanbankingnews.com - September 4 at 12:49 PM |
| Critical Comparison: 89bio (NASDAQ:ETNB) vs. Akari Therapeutics (NASDAQ:AKTX)
americanbankingnews.com - September 4 at 6:57 AM |
| 89bio Initiates Phase 2 Trial of BIO89-100 in Patients with Severe Hypertriglyceridemia
finance.yahoo.com - September 3 at 12:24 PM |
| 89bio EPS misses by $0.05
seekingalpha.com - August 13 at 7:32 PM |
| 89bio Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 13 at 7:32 PM |
| Why Earnings Season Could Be Great for 89bio (ETNB)
finance.yahoo.com - August 11 at 4:39 PM |
| How Much Of 89bio, Inc. (NASDAQ:ETNB) Do Institutions Own?
finance.yahoo.com - August 10 at 2:55 PM |
| 89bio raises $83.8M in stock offering
seekingalpha.com - July 13 at 12:46 PM |
| 89bio Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - July 13 at 12:46 PM |
| 89bio (ETNB) Jumps: Stock Rises 6.9%
finance.yahoo.com - July 10 at 9:32 AM |
| 89bio prices equity offering at $27.50
seekingalpha.com - July 8 at 9:15 AM |
| 89bio Announces Pricing of Upsized Public Offering of Common Stock
finance.yahoo.com - July 7 at 11:57 PM |
| 89bio launches equity offering
seekingalpha.com - July 6 at 9:19 AM |
| 89bio Announces Proposed Public Offering of Common Stock
finance.yahoo.com - July 6 at 9:19 AM |
| Hedge Funds Dumped 89bio, Inc. (ETNB) During The Crash
finance.yahoo.com - May 27 at 7:25 PM |
| 89bio Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 13 at 8:58 PM |
| 89bio to Present at Upcoming Investor Conferences
finance.yahoo.com - May 8 at 4:49 PM |
|
| 89bio closes enrollment in study of lead drug in NASH
seekingalpha.com - April 13 at 4:26 PM |
| 89bio Announces Closing of Enrollment in its Phase 1b/2a NASH Trial and Reports New Preclinical Data Confirming BIO89-100’s Mechanism of Action Via Potent FGF Receptor Agonism
finance.yahoo.com - April 13 at 4:26 PM |
| 89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors
finance.yahoo.com - March 25 at 6:22 PM |
| 89bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 18 at 5:34 PM |
| 89bio reports Q4 results
seekingalpha.com - March 18 at 4:15 PM |
| 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference
finance.yahoo.com - February 21 at 4:34 PM |
| Will 89bio (NASDAQ:ETNB) Spend Its Cash Wisely?
finance.yahoo.com - February 11 at 7:24 AM |
 | 89bio Inc.
www.barrons.com - January 24 at 10:32 PM |
| 89bio Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - December 18 at 5:58 PM |
| U.S. IPO Weekly Recap: NASH Biotech Jumps 69% As Multi-Billion Dollar Companies Join The Pipeline
seekingalpha.com - November 16 at 1:10 PM |
| 89bio Announces Pricing of Upsized Initial Public Offering
finance.yahoo.com - November 15 at 4:36 PM |
| 89bio Announces Presentations of BIO89-100 Data at The Liver Meeting® 2019
finance.yahoo.com - November 15 at 4:36 PM |
| 89bio Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - November 15 at 4:36 PM |
